ListarArtículos (Medicina) por materia "Secondary acute myeloid leukemia"
Mostrando ítems 1-1 de 1
-
Artículo
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
(Springer, 2021)This analysis from the phase II BRIGHT AML 1003 trial reports the long-term efficacy and safety of glasdegib + ...